Medical Article
A recent Phase II trial from CMC Vellore, NeoLOCUS, might have just challenged one of the most entrenched practices in head and neck oncology. We are moving from chemotherapy to biology-driven cancer treatment. And that shift has already begun in India. Rethinking Neoadjuvant Strategy: The NeoLOCUS Approach The NeoLOCUS trial explored a simple but

1448 Reached8 Comments








